MicroRNA dysregulation in schizophrenia

NEUROBIOLOGY OF DISEASE

卷:46

Review

Beveridge, Natalie J.^1,2,3  Cairns, Murray J.^1,2,3 

[1] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW 2308, Australia

[2] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia

[3] Schizophrenia Res Inst, Darlinghurst, NSW 2010, Australia

关键词: Schizophrenia;    MicroRNA;    Postmortem;    Neuropathology;    Gene silencing;   

DOI  :  10.1016/j.nbd.2011.12.029

来源: Elsevier

【 摘 要 】

Schizophrenia is a complex neuropsychiatric disorder that involves disturbances in neural circuitry and synaptic function. The exquisite network architecture and capacity for discreet post-synaptic remodeling of neurons requires coordination by an elaborate intracellular network of molecular signal transduction systems. The redundancy of these networks means that many combinations of gene variants have the potential to cause system dysfunction that manifest as related neurobehavioural syndromes. Recent investigation has revealed that posttranscriptional gene regulation and associated small non-coding microRNA (miRNA), are likely to be important factors shaping the topography of these networks. miRNA display complex temporospatial expression patterns in the mammalian brain and have the potential to regulate thousands of target genes by functioning as the specificity factor for intracellular gene-silencing machinery. They are emerging as key regulators of many neurodevelopmental and neurological processes as their dysregulation could lead to pervasive changes in the network structure during development and in the mature brain that are highly significant in the pathophysiology of schizophrenia. This review looks at mounting evidence that mature miRNA levels are altered in both the cerebral cortex and peripheral blood mononuclear cells (PBMCs) in schizophrenia. It also examines compelling evidence that the underlying miRNA biogenesis machinery and miRNA genes themselves are subject to disease-associated genetic mutation and epigenetic influence. Significantly. these changes in miRNA expression and associated machinery may represent new targets for pharmaceutical development, and the identification of miRNA signatures in PBMCs suggest that miRNA biomarkers of schizophrenia may also provide the basis for new clinical diagnostics. These developments have tremendous potential and highlight the significance of this avenue of research. (C) 2011 Elsevier Inc. All rights reserved.

【 授权许可】

Free